PCMA Highlights How PBMs Reduce Costs and Improve Quality
December 13, 2017
(Washington, D.C.) — Testifying today before the Energy and Commerce Subcommittee on Health, Pharmaceutical Care Management Association (PCMA) President and...
Filter by:
Choose a Topic
Filter by Year:Clear Filters- Press Releases
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHBP Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
- Value & Outcomes-Based Contracting
New CMS Data Shows PBM Tools are Restraining Prescription Drug Costs
December 07, 2017
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on the Centers for Medicare and Medicaid...
New Drugmaker Lobby Report Attempts to Deflect Blame for Higher Prices
November 30, 2017
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on a new report from the Pharmaceutical...
PCMA Statement on the CMS Medicare Part D Proposed Rule
November 17, 2017
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on the Centers for Medicare & Medicaid...
PCMA Highlights PBM Solutions to Address the Opioid Crisis
November 07, 2017
(Washington, D.C.) — Speaking today at a forum of national experts — “America’s Opioid Epidemic: Strategies for Prevention” — Pharmaceutical Care...
November 01, 2017
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on the President’s Commission on Combating Drug...
PCMA Outlines How PBMs Reduce Prescription Drug Costs Before the Senate HELP Committee
October 17, 2017
Testifying today before the U.S. Senate Committee on Health, Education, Labor & Pensions (HELP), Pharmaceutical Care Management Association (PCMA)...
PCMA Response to WSJ Op-Ed: “Insurers are Still Denying Treatments for Pre-Existing Conditions”
August 24, 2017
“Insurers are Still Denying Treatments for Pre-Existing Conditions” perfectly reflects the drug lobby’s criticism of the clinical safeguards used to...
PCMA Applauds the Administration’s Effort to Combat the Opioid Crisis
August 08, 2017
(Washington, D.C.) — As the Administration puts forward new steps to curb the rising opioid epidemic, the Pharmaceutical Care Management...
PCMA Response to Wall Street Journal PBM Article
August 07, 2017
In its attempt to find the reason for the high cost of Epipens, “Behind the Push to Keep Higher Priced...
PCMA: Inaccurate Kaiser Health News Video Sides with Drug Makers
August 04, 2017
The video (“Little Known Middlemen Who Save $$ On Medicines — But Maybe Not For You”) includes basic inaccuracies and...
July 26, 2017
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today released a new study, “Value of Direct and Indirect Remuneration...